-
Vaccine manufacturer Serum Institute of India (SSI) has filed a challenge to the Supreme Court against a 2016 amendment to the Income Tax Ac...
-
Kotak Alternate Asset Managers has announced a Rs 1,445 crore investment in the acquisition of Viatris' active pharmaceutical ingredient...
-
Acquista ********, Ossicodone, Ketamina, Ozempic (WhatsApp: +31616337954) I nostri prodotti hanno una purezza del 98-99%. E-mail di cont...
Search This Blog
Powered by Blogger.
Blog Archive
-
▼
2024
(774)
-
▼
September
(75)
- Life support withdrawal for terminally ill: IMA fl...
- Venus Remedies get market authorisations for two c...
- Linking spurious drugs with legitimate manufacture...
- Regulatory, policy reforms crucial for future of I...
- Health ministry comes up with new draft guidelines...
- Monkeypox in India: Key do's and don'ts you need t...
- Medical bills in India are rapidly becoming bigger...
- EQT to exit AGS Health, eyes $750 million valuation
- Want to make India a reliable pharmacy of world, s...
- Sequent Scientific, Viyash Life Sciences announce ...
- Carlyle Group portfolio companies in advanced talk...
- Suspended eye drops not intended to replace glasse...
- Paracetamol to pantop: CDSCO finds over 50 sub-sta...
- IHH Health eyes acquisitions to grow business: CEO...
- Piramal Pharma targets to double revenue in 5 years
- Health expenditure share against GDP increases fro...
- Testing of drugs from some nations eased
- Govt considers random testing of imported medical ...
- Common diabetic drug Metformin may become a wonder...
- PM Modi to inaugurate Penicillin-G plant in Andhra...
- PM Modi pledges USD 7.5 million to Quad Cancer Moo...
- Quad Cancer Moonshot: PM Modi announces USD 7.5 mi...
- No observations by US FDA during plant inspection:...
- Torrent Pharma gets an observation from USFDA for ...
- Suven Pharmaceuticals names Vivek Sharma as execut...
- Aster DM Health, Quality CARE inching closer to a ...
- Aurobindo to acquire 49 pc stake in GLS Pharma for...
- Lupin signs patent licence pact with Takeda for no...
- Dispute with Sanofi settled, Panacea scrip soars t...
- Combating counterfeit protein supplements: How gen...
- Panacea, Sanofi settle patent litigation over hexa...
- Panacea Biotec, Sanofi settle patent infringement ...
- Polymed lines up ₹750 crore for expansion, buys ov...
- Laurus Labs opens new R&D facility in IKP Knowled...
- 30-30-30 method for weight loss: What is it and do...
- How intravenous drips of vitamins are becoming pop...
- Drug sales get a monsoon twist in August
- Ayushman Bharat enrollment for senior citizens to ...
- Healthcare, manufacturing sector to benefit most f...
- Alkem joins $3 bn race for JB Chem as Torrent paus...
- Kiran Mazumdar-Shaw calls for innovation-driven va...
- DNA Wellness to invest Rs 200 cr to set up over 10...
- Durex makes India condom push for women, rural con...
- DCGI suspends nod to Entod's new eye drops over un...
- Bharat Biotech inks pact with Alopexx for anti-mic...
- Jaggery or sugar: Which sweetener is better for yo...
- 8 essential plants you should have for a mosquito-...
- US animal health major Zoetis expands GCC in Hyder...
- Plant for production of Penicillin G & Clavulanic ...
- Johnson & Johnson told to pay ₹35 lakh each as com...
- Fortis seeks CCI nod to buy 31.52% more in diagnos...
- EQT to acquire ChrysCap-owned healthcare BPO GeBBS
- Looking to lose weight? Try these 6 bedtime yoga p...
- Building muscle mass: Why the growing lure of prot...
- 7 bad habits to avoid after 40 for a healthier life
- Wockhardt says acted as per laws, denies Congress'...
- India takes tiny steps back from its China dependency
- Novo Nordisk not yet ready to bring in popular obe...
- Strides gets USFDA nod for Theophylline extended-r...
- India starts making key API clavulanic acid
- Alembic Pharma gets USFDA nod for generic product
- Need to strike fine balance between making hospita...
- Potential outbreak-causing dangerous viruses found...
- EQT set to acquire BPO GeBBS from ChrysCapital
- Lactose intolerant? 6 top non-dairy calcium source...
- Natco Pharma acquires 40 million shares in eGenesi...
- No link between mobile phones and brain cancer, WH...
- Cipla's vice-chairman MK Hamied resigns citing age...
- Cipla's MK Hamied resigns from the company due to ...
- Mankind: How Meerut brothers built India's 4th lar...
- Mankind Pharma eyes ₹9,000 cr via debt to stitch B...
- Alkem inks licensing pact with Takeda to introduce...
- How to control blood sugar naturally: 7 tips
- Biocon unit gets USFDA nod for generic drug
- AI-powered device successfully treats blood clot i...
-
▼
September
(75)
Recent Posts
Unordered List
Theme Support
-
Text Widget
Design by FlexiThemes | Blogger Theme by Lasantha - PremiumBloggerTemplates.com | Best Gadgets | Distributed By Gooyaabi Templates
0 comments:
Post a Comment